RHO and retinitis pigmentosa 1: Therapeutic approaches aimed at preventing rod loss and in turn cone loss in RHO mutation-initiated RP have utilized neuroprotective compounds and more recently attempts with gene editing to restore a wild-type (WT) sequence in mutant RHO (5, 13, 14, 15, 16, 17).